Annual FCF
-$76.44 M
+$52.65 M+40.78%
December 31, 2024
Summary
- As of March 10, 2025, RPTX annual free cash flow is -$76.44 million, with the most recent change of +$52.65 million (+40.78%) on December 31, 2024.
- During the last 3 years, RPTX annual FCF has risen by +$11.04 million (+12.62%).
- RPTX annual FCF is now -27201.79% below its all-time high of -$280.00 thousand, reached on December 31, 2022.
Performance
RPTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$27.32 M
+$3.21 M+10.53%
December 31, 2024
Summary
- As of March 10, 2025, RPTX quarterly free cash flow is -$27.32 million, with the most recent change of +$3.21 million (+10.53%) on December 31, 2024.
- Over the past year, RPTX quarterly FCF has stayed the same.
- RPTX quarterly FCF is now -131.09% below its all-time high of $87.89 million, reached on September 30, 2022.
Performance
RPTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$76.44 M
+$1.23 M+1.58%
December 31, 2024
Summary
- As of March 10, 2025, RPTX TTM free cash flow is -$76.44 million, with the most recent change of +$1.23 million (+1.58%) on December 31, 2024.
- Over the past year, RPTX TTM FCF has stayed the same.
- RPTX TTM FCF is now -807.63% below its all-time high of $10.80 million, reached on June 30, 2020.
Performance
RPTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
RPTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +40.8% | 0.0% | 0.0% |
| 3 y3 years | +12.6% | 0.0% | 0.0% |
| 5 y5 years | -287.4% | 0.0% | 0.0% |
RPTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | +40.8% | -131.1% | +22.8% | -1235.2% | +40.8% |
| 5 y | 5-year | <-9999.0% | +40.8% | -131.1% | +22.8% | -807.6% | +40.8% |
| alltime | all time | <-9999.0% | +40.8% | -131.1% | +22.8% | -807.6% | +40.8% |
Repare Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$76.44 M(-40.8%) | -$27.32 M(-10.5%) | -$76.44 M(-1.6%) |
| Sep 2024 | - | -$30.54 M(+0.1%) | -$77.67 M(-2.9%) |
| Jun 2024 | - | -$30.51 M(-355.7%) | -$80.01 M(-5.8%) |
| Mar 2024 | - | $11.93 M(-141.8%) | -$84.90 M(-34.2%) |
| Dec 2023 | -$129.10 M(>+9900.0%) | -$28.55 M(-13.1%) | -$129.10 M(+0.5%) |
| Sep 2023 | - | -$32.87 M(-7.2%) | -$128.46 M(+1568.9%) |
| Jun 2023 | - | -$35.41 M(+9.8%) | -$7.70 M(+275.8%) |
| Mar 2023 | - | -$32.26 M(+15.6%) | -$2.05 M(+631.4%) |
| Dec 2022 | -$280.00 K(-99.7%) | -$27.92 M(-131.8%) | -$280.00 K(-104.2%) |
| Sep 2022 | - | $87.89 M(-395.3%) | $6.73 M(-105.9%) |
| Jun 2022 | - | -$29.76 M(-2.4%) | -$114.25 M(+10.9%) |
| Mar 2022 | - | -$30.49 M(+45.9%) | -$102.98 M(+17.7%) |
| Dec 2021 | -$87.49 M | -$20.90 M(-36.8%) | -$87.49 M(+7.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$33.10 M(+79.0%) | -$81.25 M(+18.2%) |
| Jun 2021 | - | -$18.49 M(+23.3%) | -$68.73 M(+406.4%) |
| Mar 2021 | - | -$15.00 M(+2.3%) | -$13.57 M(+63.1%) |
| Dec 2020 | -$8.32 M(-57.8%) | -$14.67 M(-28.7%) | -$8.32 M(+122.4%) |
| Sep 2020 | - | -$20.58 M(-156.1%) | -$3.74 M(-134.6%) |
| Jun 2020 | - | $36.67 M(-476.2%) | $10.80 M(-133.5%) |
| Mar 2020 | - | -$9.75 M(-3.4%) | -$32.25 M(+63.4%) |
| Dec 2019 | -$19.73 M(+49.5%) | -$10.09 M(+67.3%) | -$19.73 M(+104.6%) |
| Sep 2019 | - | -$6.03 M(-5.5%) | -$9.64 M(+167.0%) |
| Jun 2019 | - | -$6.38 M(-330.4%) | -$3.61 M(-230.4%) |
| Mar 2019 | - | $2.77 M | $2.77 M |
| Dec 2018 | -$13.20 M(+84.3%) | - | - |
| Dec 2017 | -$7.16 M | - | - |
FAQ
- What is Repare Therapeutics annual free cash flow?
- What is the all time high annual FCF for Repare Therapeutics?
- What is Repare Therapeutics annual FCF year-on-year change?
- What is Repare Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Repare Therapeutics?
- What is Repare Therapeutics quarterly FCF year-on-year change?
- What is Repare Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Repare Therapeutics?
- What is Repare Therapeutics TTM FCF year-on-year change?
What is Repare Therapeutics annual free cash flow?
The current annual FCF of RPTX is -$76.44 M
What is the all time high annual FCF for Repare Therapeutics?
Repare Therapeutics all-time high annual free cash flow is -$280.00 K
What is Repare Therapeutics annual FCF year-on-year change?
Over the past year, RPTX annual free cash flow has changed by +$52.65 M (+40.78%)
What is Repare Therapeutics quarterly free cash flow?
The current quarterly FCF of RPTX is -$27.32 M
What is the all time high quarterly FCF for Repare Therapeutics?
Repare Therapeutics all-time high quarterly free cash flow is $87.89 M
What is Repare Therapeutics quarterly FCF year-on-year change?
Over the past year, RPTX quarterly free cash flow has changed by $0.00 (0.00%)
What is Repare Therapeutics TTM free cash flow?
The current TTM FCF of RPTX is -$76.44 M
What is the all time high TTM FCF for Repare Therapeutics?
Repare Therapeutics all-time high TTM free cash flow is $10.80 M
What is Repare Therapeutics TTM FCF year-on-year change?
Over the past year, RPTX TTM free cash flow has changed by $0.00 (0.00%)